BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8636550)

  • 1. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction.
    Arakawa N; Nakamura M; Aoki H; Hiramori K
    J Am Coll Cardiol; 1996 Jun; 27(7):1656-61. PubMed ID: 8636550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.
    Morita E; Yasue H; Yoshimura M; Ogawa H; Jougasaki M; Matsumura T; Mukoyama M; Nakao K
    Circulation; 1993 Jul; 88(1):82-91. PubMed ID: 8319360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Yandle TG; Frampton C; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Ikram H; Crozier IG; Smyth DW
    Circulation; 1998 May; 97(19):1921-9. PubMed ID: 9609085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma natriuretic peptides as indicators of left ventricular remodeling after myocardial infarction.
    Yoshitomi Y; Nishikimi T; Kojima S; Kuramochi M; Takishita S; Kangawa K; Matsuo H
    Int J Cardiol; 1998 Apr; 64(2):153-60. PubMed ID: 9688434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction.
    Nagaya N; Nishikimi T; Goto Y; Miyao Y; Kobayashi Y; Morii I; Daikoku S; Matsumoto T; Miyazaki S; Matsuoka H; Takishita S; Kangawa K; Matsuo H; Nonogi H
    Am Heart J; 1998 Jan; 135(1):21-8. PubMed ID: 9453517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function.
    Bonarjee VV; Omland T; Nilsen DW; Caidahl K; Sundsfjord JA; Dickstein K
    Br Heart J; 1995 Jun; 73(6):511-6. PubMed ID: 7626348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.
    Motwani JG; McAlpine H; Kennedy N; Struthers AD
    Lancet; 1993 May; 341(8853):1109-13. PubMed ID: 8097802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton C; Turner J; Crozier IG; Yandle TG
    Circulation; 2003 Jun; 107(22):2786-92. PubMed ID: 12771003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study.
    Vantrimpont P; Rouleau JL; Ciampi A; Harel F; de Champlain J; Bichet D; Moyé LA; Pfeffer M
    Eur Heart J; 1998 Oct; 19(10):1552-63. PubMed ID: 9820995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain natriuretic peptide and other cardiac markers predicting left ventricular remodeling and function two years after myocardial infarction.
    Grybauskiene R; Karciauskaite D; Brazdzionyte J; Janenaite J; Bertasiene Z; Grybauskas P
    Medicina (Kaunas); 2007; 43(9):708-15. PubMed ID: 17986844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity.
    Miyao Y; Nishikimi T; Goto Y; Miyazaki S; Daikoku S; Morii I; Matsumoto T; Takishita S; Miyata A; Matsuo H; Kangawa K; Nonogi H
    Heart; 1998 Jan; 79(1):39-44. PubMed ID: 9505917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction.
    Talwar S; Squire IB; Downie PF; Mccullough AM; Campton MC; Davies JE; Barnett DB; Ng LL
    Eur Heart J; 2000 Sep; 21(18):1514-21. PubMed ID: 10973765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of exercise on plasma adrenomedullin and natriuretic peptide levels in myocardial infarction.
    Morimoto A; Nishikimi T; Takaki H; Okano Y; Matsuoka H; Takishita S; Kitamura K; Miyata A; Kangawa K; Matsuo H
    Clin Exp Pharmacol Physiol; 1997 May; 24(5):315-20. PubMed ID: 9143780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
    J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of plasma levels of atrial natriuretic factor in patients with acute myocardial infarction.
    Nakamura M; Arakawa N; Yoshida H; Funakoshi T; Chiba M; Makita S; Aoki H; Hiramori K
    Intern Med; 1993 Feb; 32(2):112-5. PubMed ID: 8507921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction.
    Darbar D; Davidson NC; Gillespie N; Choy AM; Lang CC; Shyr Y; McNeill GP; Pringle TH; Struthers AD
    Am J Cardiol; 1996 Aug; 78(3):284-7. PubMed ID: 8759805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentration of atrial natriuretic peptide at admission and risk of cardiac death in patients with acute myocardial infarction.
    Svanegaard J; Angelo-Nielsen K; Pindborg T
    Br Heart J; 1992 Jul; 68(1):38-42. PubMed ID: 1387544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.
    Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW
    Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain natriuretic peptide and other cardiac markers in predicting left ventricular remodeling in patients with the first myocardial infarction.
    Karciauskaite D; Grybauskiene R; Grybauskas P; Janenaite J
    Medicina (Kaunas); 2004; 40(10):949-56. PubMed ID: 15516817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.